Semaglutide Program

The Semaglutide Program is a pathway to discuss whether a GLP-1 receptor agonist belongs in your weight-management plan. Certain FDA-approved semaglutide products have a chronic weight-management indication; other products have different indications. Your physician evaluates the exact product, labeling, and your individual circumstances. This program does not promise a prescription, a specific formulation, or an amount of weight loss. Medication, when appropriate, sits alongside nutrition, movement, and ongoing review rather than replacing them.

Semaglutide influences appetite-related signaling and slows gastric emptying. Injectable weight-management regimens generally involve a clinician-directed, gradual escalation rather than starting at a high dose. Nausea, vomiting, diarrhea, and constipation can occur. Your physician needs to review contraindications, including product-specific thyroid tumor warnings, pregnancy considerations, other medications, and procedures involving anesthesia. Ask how to manage tolerability and when symptoms require urgent care. Published trial findings for an approved product do not establish equivalent outcomes for compounded preparations.

A program begins with a clinical conversation, not an order for a preselected prescription. Medical intake belongs in Qualiphy, the designated telehealth assessment provider, rather than in a general website form. A licensed physician considers your history, current medications, goals, relevant examination findings, and any testing needed to make a responsible recommendation. Completing an assessment does not mean you qualify, and browsing a program does not establish that it is available or suitable for you.

If an appropriate plan is recommended, ask for a clear explanation of the exact treatment, its intended purpose, evidence, alternatives, and practical requirements. Your provider should distinguish an FDA-approved product from a compounded preparation or an investigational option. Compounded medications are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality. An ingredient name alone does not establish equivalence, and a program title is not an approval claim for every treatment that might be discussed.

The care experience should include an opportunity to understand monitoring, possible adverse effects, and how to communicate concerns. Confirm the frequency and format of follow-up, whether laboratory testing is needed, and which services are included versus billed separately. Prescriptions, dose adjustments, and refills remain clinical decisions. Never change a prescribed dose, combine treatments, or rely on a website description as a substitute for instructions from your licensed provider. Seek urgent medical help for severe symptoms rather than waiting for a routine message.

LavION Health is a physician-guided medical wellness practice based in Phoenix, Arizona, led by Medical Director Dr. Keith Johnson. People in Scottsdale, Paradise Valley, Arcadia, and the greater Phoenix area can ask about the appropriate next step. Telehealth depends on provider licensure, your location, and clinical circumstances; some needs require an in-person visit or another specialist. Current pricing, pharmacy arrangements, shipping eligibility, and cancellation terms must be confirmed before you make a financial commitment. Individual results vary, and choosing not to proceed can be the right outcome.